Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: The Business Research Company | PRODUCT CODE: 1948187

Cover Image

PUBLISHER: The Business Research Company | PRODUCT CODE: 1948187

Research Antibodies And Reagents Global Market Opportunities And Strategies To 2034

PUBLISHED:
PAGES: 346 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 4490
PDF & Excel (Site License)
USD 6490
PDF & Excel (Enterprise License)
USD 8490

Add to Cart

Research antibodies and reagents are specialized biological tools used in scientific experiments to detect, quantify, and study specific molecules such as proteins, nucleic acids, or cellular components. Antibodies bind selectively to target antigens, while reagents such as buffers, enzymes, dyes, and substrates support various laboratory techniques, including immunoassays, flow cytometry, Western blotting, and molecular biology studies. The primary purpose of research antibodies and reagents is to enable accurate and reproducible biological research by facilitating the identification, characterization, and analysis of biomolecules.

The global research antibodies and reagents market reached a value of nearly $16,254.74 million in 2024, having grown at a compound annual growth rate (CAGR) of 7.75% since 2019. The market is expected to grow from $16,254.74 million in 2024 to $22,760.24 million in 2029 at a rate of 6.96%. The market is then expected to grow at a CAGR of 6.65% from 2029 and reach $31,404.45 million in 2034.

Expansion Of Contract Research Organizations (CROS)

Expansion of contract research organizations (CROs) contributed to the growth of the research antibodies and reagents market in the historic period. The growth of CROs has positively impacted the research antibodies and reagents market. CROs provide outsourced research services, conducting experiments, assays, and validations on behalf of pharmaceutical and biotechnology companies. As CROs expand globally and handle more research projects, they increase the need for high-quality antibodies and reagents, further driving demand and market growth. For example, in September 2023, according to Bdaily UK, a UK-based local business news outlet, Gentronix, a CRO based in Cheshire, added a new 96-well toxicology assay with automated slide scoring and expanded its laboratory and office space at Alderley Park, illustrating a capacity-building expansion in CRO services in the UK. Therefore, the expansion of contract research organizations (CROs) drove the growth of the research antibodies and reagents market.

Integration Of Automated Western Blotting Systems

Major companies in the research antibodies are increasing their offerings of automated Western blot platforms to improve throughput, reproducibility, and workflow standardization. In response to demands for higher throughput, better reproducibility, and streamlined workflows in protein analysis, companies are increasingly developing fully automated Western blot platforms that reduce manual steps and variability. For example, in July 2024, Bio-Techne, a US-based global life sciences company, introduced the Leo(TM) Simple Western System, expanding on its Simple Western line to offer higher throughput and full automation of traditional Western blot workflows. The Leo system allows processing of up to 100 samples in a single 3-hour run and is designed for both discovery research and bioanalytical applications. It is fully automated capillary western blotting that replaces traditional western blotting workflows, providing reproducibility, high sensitivity, and quantitative protein detection.

The global research antibodies and reagents market is fairly concentrated, with large players operating in the market. The top ten competitors in the market made up to 31.80% of the total market in 2024.

Research Antibodies And Reagents Global Market Opportunities And Strategies To 2034 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global research antibodies and reagents market as it emerges from the COVID-19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for research antibodies and reagents? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The research antibodies and reagents market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider research antibodies and reagents market; and compares it with other markets.

The report covers the following chapters

  • Introduction and Market Characteristics:- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by technology, by application and by end user.
  • Key Trends:- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
  • Growth Analysis And Strategic Analysis Framework:- Analysis on PESTEL, end use industries, market growth rate, global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods, forecast growth contributors and total addressable market (TAM).
  • Regional And Country Analysis:- Historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison by region and country.
  • Market Segmentation:- Contains the market values (2019-2024) (2024-2029, 2034F) and analysis for each segment by technology, by application and by end user in the market. Historic (2019-2024) and forecast (2024-2029) and (2029-2034) market values and growth and market share comparison by region market.
  • Regional Market Size And Growth:- Regional market size (2024), historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
  • Competitive Landscape:- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
  • Other Major And Innovative Companies:- Details on the company profiles of other major and innovative companies in the market.
  • Competitive Benchmarking:- Briefs on the financials comparison between major players in the market.
  • Competitive Dashboard:- Briefs on competitive dashboard of major players.
  • Key Mergers and Acquisitions:- Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
  • Recent Developments:- Information on recent developments in the market covered in the report.
  • Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
  • Conclusions And Recommendations- This section includes recommendations for research antibodies and reagents providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
  • Appendix:- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

  • 1) By Technology: Western blot; Immunofluorescence; Immunohistochemistry; Flow Cytometry; Enzyme-Linked Immunosorbent Assay (ELISA); Others
  • 2) By Application: Proteomics; Genomics; Other Applications
  • 3) By End User: Pharmaceutical And Biotechnology Industry; Academic And Research Institutes; Contract Research Organizations (CROs)
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Danaher Corporation (Abcam); Merck KGaA; F. Hoffmann-La Roche AG; Revvity Inc. (formerly, PerkinElmer Inc.) (BioLegend)
  • Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; UK; Italy; Spain; Russia
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time-series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; research antibodies and reagents indicators comparison.
  • Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Product Code: PH4MRARN01_O25Q4

Table of Contents

1 Executive Summary

  • 1.1 Research Antibodies And Reagents - Market Attractiveness And Macro Economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

  • 6.1 General Market Definition
  • 6.2 Summary
  • 6.3 Research Antibodies and Reagents Market Definition And Segmentations
  • 6.4 Market Segmentation By Technology
    • 6.4.1 Western Blot
    • 6.4.2 Immunofluorescence
    • 6.4.3 Immunohistochemistry
    • 6.4.4 Flow Cytometry
    • 6.4.5 Enzyme-Linked Immunosorbent Assay (ELISA)
    • 6.4.6 Others
  • 6.5 Market Segmentation By Application
    • 6.5.1 Proteomics
    • 6.5.2 Genomics
    • 6.5.3 Other Applications
  • 6.6 Market Segmentation By End User
    • 6.6.1 Pharmaceutical And Biotechnology Industry
    • 6.6.2 Academic And Research Institutes
    • 6.6.3 Contract Research Organizations (CROs)

7 Major Market Trends

  • 7.1 Integration Of Automated Western Blotting Systems
  • 7.2 Development Of High-Parameter Flow Cytometry Platforms
  • 7.3 Advancement Of Multiplexed Immunofluorescence Imaging

8 Research Antibodies And Reagents Growth Analysis And Strategic Analysis Framework

  • 8.1 Global Research Antibodies And Reagents PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors)
    • 8.1.1 Political
    • 8.1.2 Economic
    • 8.1.3 Social
    • 8.1.4 Technological
    • 8.1.5 Environmental
    • 8.1.6 Legal
  • 8.2 Analysis Of End User (B2B) Market
    • 8.2.1 Pharmaceutical And Biotechnology Industry
    • 8.2.2 Academic And Research Institutes
    • 8.2.3 Contract Research Organizations (CROs)
  • 8.3 Research Antibodies And Reagents Market Growth Rate Analysis
  • 8.4 Global Historic Market Growth, 2019 - 2024, Value ($ Million)
    • 8.4.1 Market Drivers 2019 - 2024
    • 8.4.2 Market Restraints 2019 - 2024
  • 8.5 Global Forecast Market Growth, 2024 - 2029, 2034F Value ($ Million)
  • 8.6 Forecast Growth Contributors/Factors
    • 8.6.1 Quantitative Growth Contributors
    • 8.6.2 Drivers
    • 8.6.3 Restraints
  • 8.7 Total Addressable Market for the Research Antibodies and Reagents Market
    • 8.7.1 TAM Comparison Analysis

9 Research Antibodies And Reagents Market Segmentation

  • 9.1 Global Research Antibodies And Reagents Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.2 Global Research Antibodies And Reagents Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.3 Global Research Antibodies And Reagents Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.4 Global Research Antibodies And Reagents Market, Sub-Segmentation Of Western Blot, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.5 Global Research Antibodies And Reagents Market, Sub-Segmentation Immunofluorescence, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.6 Global Research Antibodies And Reagents Market, Sub-Segmentation Immunohistochemistry, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.7 Global Research Antibodies And Reagents Market, Sub-Segmentation Flow Cytometry, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.8 Global Research Antibodies And Reagents Market, Sub-Segmentation Enzyme-Linked Immunosorbent Assay (ELISA), By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.9 Global Research Antibodies And Reagents Market, Sub-Segmentation Others, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

10 Research Antibodies And Reagents Market, Regional and Country Analysis

  • 10.1 Research Antibodies And Reagents Market, By Region, Historic and Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 10.2 Research Antibodies And Reagents Market, By Country, Historic and Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

11 Asia-Pacific Market

  • 11.1 Summary
  • 11.2 Market Overview
    • 11.2.1 Region Information
    • 11.2.2 Market Information
    • 11.2.3 Background Information
    • 11.2.4 Government Initiatives
    • 11.2.5 Regulations
    • 11.2.6 Major Associations
    • 11.2.7 Taxes Levied
    • 11.2.8 Corporate Tax Structure
    • 11.2.9 Major Companies
  • 11.3 Asia-Pacific Research Antibodies And Reagents Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.4 Asia-Pacific Research Antibodies And Reagents Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.5 Asia-Pacific Research Antibodies And Reagents Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.6 Asia-Pacific Research Antibodies And Reagents Market: Country Analysis
  • 11.7 China Market
  • 11.8 Summary
  • 11.9 Market Overview
    • 11.9.1 Country Information
    • 11.9.2 Market Information
    • 11.9.3 Background Information
    • 11.9.4 Government Initiatives
    • 11.9.5 Regulations
    • 11.9.6 Major Associations
    • 11.9.7 Taxes Levied
    • 11.9.8 Corporate Tax Structure
    • 11.9.9 Major Companies
  • 11.10 China Research Antibodies And Reagents Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.11 China Research Antibodies And Reagents Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.12 China Research Antibodies And Reagents Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.13 India Market
  • 11.14 India Research Antibodies And Reagents Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.15 India Research Antibodies And Reagents Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.16 India Research Antibodies And Reagents Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.17 Japan Market
  • 11.18 Summary
  • 11.19 Market Overview
    • 11.19.1 Country Information
    • 11.19.2 Market Information
    • 11.19.3 Background Information
    • 11.19.4 Government Initiatives
    • 11.19.5 Regulations
    • 11.19.6 Major Associations
    • 11.19.7 Taxes Levied
    • 11.19.8 Corporate Tax Structure
    • 11.19.9 Major Companies
  • 11.20 Japan Research Antibodies And Reagents Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.21 Japan Research Antibodies And Reagents Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.22 Japan Research Antibodies And Reagents Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.23 Australia Market
  • 11.24 Australia Research Antibodies And Reagents Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.25 Australia Research Antibodies And Reagents Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.26 Australia Research Antibodies And Reagents Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.27 Indonesia Market
  • 11.28 Indonesia Research Antibodies And Reagents Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.29 Indonesia Research Antibodies And Reagents Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.30 Indonesia Research Antibodies And Reagents Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.31 South Korea Market
  • 11.32 Summary
  • 11.33 Market Overview
    • 11.33.1 Country Information
    • 11.33.2 Market Information
    • 11.33.3 Background Information
    • 11.33.4 Government Initiatives
    • 11.33.5 Regulations
    • 11.33.6 Major Associations
    • 11.33.7 Taxes Levied
    • 11.33.8 Corporate Tax Structure
    • 11.33.9 Major Companies
  • 11.34 South Korea Research Antibodies And Reagents Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.35 South Korea Research Antibodies And Reagents Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.36 South Korea Research Antibodies And Reagents Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

12 Western Europe Market

  • 12.1 Summary
  • 12.2 Market Overview
    • 12.2.1 Region Information
    • 12.2.2 Market Information
    • 12.2.3 Background Information
    • 12.2.4 Government Initiatives
    • 12.2.5 Regulations
    • 12.2.6 Major Associations
    • 12.2.7 Taxes Levied
    • 12.2.8 Corporate tax structure
    • 12.2.9 Investments
    • 12.2.10 Major Companies
  • 12.3 Western Europe Research Antibodies And Reagents Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.4 Western Europe Research Antibodies And Reagents Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.5 Western Europe Research Antibodies And Reagents Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.6 Western Europe Research Antibodies And Reagents Market: Country Analysis
  • 12.7 UK Market
  • 12.8 UK Research Antibodies And Reagents Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.9 UK Research Antibodies And Reagents Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.10 UK Research Antibodies And Reagents Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.11 Germany Market
  • 12.12 Germany Research Antibodies And Reagents Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.13 Germany Research Antibodies And Reagents Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.14 Germany Research Antibodies And Reagents Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.15 France Market
  • 12.16 France Research Antibodies And Reagents Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.17 France Research Antibodies And Reagents Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.18 France Research Antibodies And Reagents Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.19 Italy Market
  • 12.20 Italy Research Antibodies And Reagents Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.21 Italy Research Antibodies And Reagents Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.22 Italy Research Antibodies And Reagents Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.23 Spain Market
  • 12.24 Spain Research Antibodies And Reagents Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.25 Spain Research Antibodies And Reagents Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.26 Spain Research Antibodies And Reagents Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

13 Eastern Europe Market

  • 13.1 Summary
  • 13.2 Market Overview
    • 13.2.1 Region Information
    • 13.2.2 Market Information
    • 13.2.3 Background Information
    • 13.2.4 Government Initiatives
    • 13.2.5 Regulations
    • 13.2.6 Major Associations
    • 13.2.7 Taxes Levied
    • 13.2.8 Corporate Tax Structure
    • 13.2.9 Major companies
  • 13.3 Eastern Europe Research Antibodies And Reagents Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.4 Eastern Europe Research Antibodies And Reagents Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.5 Eastern Europe Research Antibodies And Reagents Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.6 Eastern Europe Research Antibodies And Reagents Market: Country Analysis
  • 13.7 Russia Market
  • 13.8 Russia Research Antibodies And Reagents Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.9 Russia Research Antibodies And Reagents Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.10 Russia Research Antibodies And Reagents Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

14 North America Market

  • 14.1 Summary
  • 14.2 Market Overview
    • 14.2.1 Region Information
    • 14.2.2 Market Information
    • 14.2.3 Background Information
    • 14.2.4 Government Initiatives
    • 14.2.5 Regulations
    • 14.2.6 Major Associations
    • 14.2.7 Taxes Levied
    • 14.2.8 Corporate Tax Structure
    • 14.2.9 Investments
    • 14.2.10 Major Companies
  • 14.3 North America Research Antibodies And Reagents Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.4 North America Research Antibodies And Reagents Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.5 North America Research Antibodies And Reagents Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.6 North America Research Antibodies And Reagents Market: Country Analysis
  • 14.7 USA Market
  • 14.8 Summary
  • 14.9 Market Overview
    • 14.9.1 Country Information
    • 14.9.2 Market Information
    • 14.9.3 Background Information
    • 14.9.4 Government Initiatives
    • 14.9.5 Regulations
    • 14.9.6 Major Associations
    • 14.9.7 Taxes Levied
    • 14.9.8 Corporate Tax Structure
    • 14.9.9 Investments
    • 14.9.10 Major Companies
  • 14.10 USA Research Antibodies And Reagents Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.11 USA Research Antibodies And Reagents Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.12 USA Research Antibodies And Reagents Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.13 Canada Market
  • 14.14 Summary
  • 14.15 Market Overview
    • 14.15.1 Country Information
    • 14.15.2 Market Information
    • 14.15.3 Background Information
    • 14.15.4 Government Initiatives
    • 14.15.5 Regulations
    • 14.15.6 Major Associations
    • 14.15.7 Taxes Levied
    • 14.15.8 Corporate Tax Structure
    • 14.15.9 Major Companies
  • 14.16 Canada Research Antibodies And Reagents Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.17 Canada Research Antibodies And Reagents Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.18 Canada Research Antibodies And Reagents Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

15 South America Market

  • 15.1 Summary
  • 15.2 Market Overview
    • 15.2.1 Region Information
    • 15.2.2 Market Information
    • 15.2.3 Background Information
    • 15.2.4 Government Initiatives
    • 15.2.5 Regulations
    • 15.2.6 Major Associations
    • 15.2.7 Taxes Levied
    • 15.2.8 Corporate Tax Structure
    • 15.2.9 Major Companies
  • 15.3 South America Research Antibodies And Reagents Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.4 South America Research Antibodies And Reagents Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.5 South America Research Antibodies And Reagents Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.6 South America Research Antibodies And Reagents Market: Country Analysis
  • 15.7 Brazil Market
  • 15.8 Brazil Research Antibodies And Reagents Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.9 Brazil Research Antibodies And Reagents Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.10 Brazil Research Antibodies And Reagents Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

16 Middle East Market

  • 16.1 Summary
  • 16.2 Market Overview
    • 16.2.1 Region Information
    • 16.2.2 Market Information
    • 16.2.3 Background Information
    • 16.2.4 Government Initiatives
    • 16.2.5 Regulations
    • 16.2.6 Taxes Levied
    • 16.2.7 Corporate Tax Structure
    • 16.2.8 Major Companies
  • 16.3 Middle East Research Antibodies And Reagents Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 16.4 Middle East Research Antibodies And Reagents Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 16.5 Middle East Research Antibodies And Reagents Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

17 Africa Market

  • 17.1 Summary
  • 17.2 Market Overview
    • 17.2.1 Region Information
    • 17.2.2 Market Information
    • 17.2.3 Background Information
    • 17.2.4 Government Initiatives
    • 17.2.5 Regulations
    • 17.2.6 Major Associations
    • 17.2.7 Taxes Levied
    • 17.2.8 Corporate Tax Structure
    • 17.2.9 Major Companies
  • 17.3 Africa Research Antibodies And Reagents Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 17.4 Africa Research Antibodies And Reagents Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 17.5 Africa Research Antibodies And Reagents Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

18 Competitive Landscape And Company Profiles

  • 18.1 Company Profiles
  • 18.2 Thermo Fisher Scientific Inc
    • 18.2.1 Company Overview
    • 18.2.2 Products And Services
    • 18.2.3 Business Strategy
    • 18.2.4 Financial Overview
  • 18.3 Danaher Corporation (Abcam plc)
    • 18.3.1 Company Overview
    • 18.3.2 Products And Services
    • 18.3.3 Business Strategy
    • 18.3.4 Financial Overview
  • 18.4 Merck KGaA
    • 18.4.1 Company Overview
    • 18.4.2 Products And Services
    • 18.4.3 Business Strategy
    • 18.4.4 Financial Overview
  • 18.5 F. Hoffman-La Roche Ltd
    • 18.5.1 Company Overview
    • 18.5.2 Products And Services
    • 18.5.3 Business Strategy
    • 18.5.4 Financial Overview
  • 18.6 Revvity Inc. (formerly, PerkinElmer Inc.) (BioLegend)
    • 18.6.1 Company Overview
    • 18.6.2 Products And Services
    • 18.6.3 Business Strategy
    • 18.6.4 Financial Overview

19 Other Major And Innovative Companies

  • 19.1 Bio-Techne Corporation
    • 19.1.1 Company Overview
    • 19.1.2 Products and Services
  • 19.2 Agilent Technologies Inc.
    • 19.2.1 Company Overview
    • 19.2.2 Products and Services
  • 19.3 Becton, Dickinson and Company (BD)
    • 19.3.1 Company Overview
    • 19.3.2 Products and Services
  • 19.4 Bio-Rad Laboratories Inc.
    • 19.4.1 Company Overview
    • 19.4.2 Products and Services
  • 19.5 Takara Bio Inc.
    • 19.5.1 Company Overview
    • 19.5.2 Products and Services
  • 19.6 Qiagen N.V.
    • 19.6.1 Company Overview
    • 19.6.2 Products and Services
  • 19.7 Cell Signaling Technology Inc.
    • 19.7.1 Company Overview
    • 19.7.2 Products and Services
  • 19.8 OriGene Technologies, Inc.
    • 19.8.1 Company Overview
    • 19.8.2 Products and Services
  • 19.9 Sino Biological Inc.
    • 19.9.1 Company Overview
    • 19.9.2 Products and Services
  • 19.10 Cytek Biosciences Inc.
    • 19.10.1 Company Overview
    • 19.10.2 Products and Services
  • 19.11 ACROBiosystems Inc.
    • 19.11.1 Company Overview
    • 19.11.2 Products and Services
  • 19.12 Atlas Antibodies
    • 19.12.1 Company Overview
    • 19.12.2 Products and Services
  • 19.13 Rockland Immunochemicals Inc.
    • 19.13.1 Company Overview
    • 19.13.2 Products and Services
  • 19.14 Santa Cruz Biotechnology Inc.
    • 19.14.1 Company Overview
    • 19.14.2 Products and Services
  • 19.15 Promega Corporation
    • 19.15.1 Company Overview
    • 19.15.2 Products and Services

20 Competitive Benchmarking

21 Competitive Dashboard

22 Key Mergers And Acquisitions

  • 22.1 Leinco Technologies Inc. Acquired QED Biosciences Inc.
  • 22.2 Danaher Corporation Acquired Abcam

23 Recent Developments In Research Antibodies And Reagents

  • 23.1 Accelerating Antibody Selection With AI-Driven Tools
  • 23.2 Accelerating Single-Cell And Reagent Dispensing With Duo Digital Dispenser

24 Opportunities And Strategies

  • 24.1 Research Antibodies And Reagents Market In 2029 - Countries Offering Most New Opportunities
  • 24.2 Research Antibodies And Reagents Market In 2029 - Segments Offering Most New Opportunities
  • 24.3 Research Antibodies And Reagents Market In 2029 - Growth Strategies
    • 24.3.1 Market Trend Based Strategies
    • 24.3.2 Competitor Strategies

25 Research Antibodies And Reagents Market, Conclusions And Recommendations

  • 25.1 Conclusions
  • 25.2 Recommendations
    • 25.2.1 Product
    • 25.2.2 Place
    • 25.2.3 Price
    • 25.2.4 Promotion
    • 25.2.5 People

26 Appendix

  • 26.1 Geographies Covered
  • 26.2 Market Data Sources
  • 26.3 Research Methodology
  • 26.4 Currencies
  • 26.5 The Business Research Company
  • 26.6 Copyright and Disclaimer
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!